Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lannett Company Inc (NYSE:LCI)

19.02
Delayed Data
As of 1:48pm ET
 -0.53 / -2.69%
Today’s Change
16.75
Today|||52-Week Range
39.99
-13.72%
Year-to-Date

Today’s Trading

Previous close19.55
Today’s open19.35
Day’s range18.85 - 19.55
Volume1,116,969
Average volume (3 months)1,136,741
Market cap$726.5M
Dividend yield--
Data as of 1:48pm ET, 01/18/2017

Growth & Valuation

Earnings growth (last year)-70.30%
Earnings growth (this year)-1.85%
Earnings growth (next 5 years)+8.50%
Revenue growth (last year)+39.14%
P/E ratioNM
Price/Sales1.57
Price/Book1.29

Competitors

 Today’s
change
Today’s
% change
ACRSAclaris Therapeutics...-0.09-0.32%
ACIUAC Immune Ltd-0.11-0.83%
INSYINSYS Therapeutics I...+0.60+5.83%
AMPHAmphastar Pharmaceut...+0.10+0.61%
Data as of 2:02pm ET, 01/18/2017

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)$0.84
Annual revenue (last year)$566.1M
Annual profit (last year)$44.8M
Net profit margin7.91%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Arthur P. Bedrosian
CFO, Treasurer &
Vice President-Finance
Martin P. Galvan
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts


Search for Jobs